{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:13:51Z","timestamp":1794554031629,"version":"4.9.1"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuroscience.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:52:59Z","timestamp":1751457179000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Parkinson\u2019s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons"],"prefix":"10.1016","volume":"581","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6040-2284","authenticated-orcid":false,"given":"Satyam","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8777-4628","authenticated-orcid":false,"given":"Rojin G.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.07.003_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-publhealth-012420-105020","article-title":"Environmental influences on the human microbiome and implications for noncommunicable disease","volume":"42","author":"Ahn","year":"2021","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0015","series-title":"Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders","first-page":"641","article-title":"Prebiotics and probiotics and Parkinson\u2019s disease","author":"Amani","year":"2023"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0020","doi-asserted-by":"crossref","first-page":"23095","DOI":"10.1038\/s41598-024-74400-w","article-title":"Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson\u2019s disease: results from an open label single-arm study","volume":"14","author":"Andreozzi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0025","unstructured":"Antibiotics and Antifungals May Slightly Affect Parkinson\u2019s Risk, Study Finds | Rutgers University n.d. https:\/\/www.rutgers.edu\/news\/antibiotics-and-antifungals-may-slightly-affect-parkinsons-risk-study-finds (accessed November 30, 2024)."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/nutrit\/nuv019","article-title":"Microbiota and the gut\u2013brain axis","volume":"73","author":"Bienenstock","year":"2015","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","article-title":"Aging and Parkinson\u2019s disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis","volume":"115","author":"Calabrese","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ebiom.2016.09.029","article-title":"Fecal microbiota-based therapeutics for recurrent clostridium difficile infection, ulcerative colitis and obesity","volume":"13","author":"Carlucci","year":"2016","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0070","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12974-023-02720-1","article-title":"\u03b1-Synuclein induces prodromal symptoms of Parkinson\u2019s disease via activating TLR2\/MyD88\/NF-\u03baB pathway in Schwann cells of vagus nerve in a rat model","volume":"20","author":"Cheng","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0080","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0085","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1039\/D2FO03825K","article-title":"Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson\u2019s disease","volume":"14","author":"Chu","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0090","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042067","article-title":"Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism","volume":"7","author":"Corridoni","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2982.2010.01664.x","article-title":"The microbiome-gut-brain axis: from bowel to behavior","volume":"23","author":"Cryan","year":"2011","journal-title":"Neurogastroenterol. Motility"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0110","article-title":"Parkinson\u2019s disease, diet and gut microbiota alterations","volume":"6","author":"David Armando","year":"2023","journal-title":"J. Neurodegenerative Dis."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0115","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11910-024-01339-w","article-title":"Epidemiology of Parkinson\u2019s disease: an update","volume":"24","author":"Deliz","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic\u2014a call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson\u2019s disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5056\/jnm19044","article-title":"Parkinson\u2019s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation","volume":"25","author":"Dutta","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0145","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41467-017-01973-8","article-title":"Meta-analysis of gut microbiome studies identifies disease-specific and shared responses","volume":"8","author":"Duvallet","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41531-022-00318-7","article-title":"Association between inflammatory bowel disease and Parkinson\u2019s disease: a Mendelian randomization study","volume":"8","author":"Freuer","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0155","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.clinph.2008.03.017","article-title":"Pathophysiology of Parkinsonism","volume":"119","author":"Galvan","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"351","key":"10.1016\/j.neuroscience.2025.07.003_b0165","first-page":"1296","article-title":"The maternal microbiota drives early postnatal innate immune development","volume":"2016","author":"Gomez de Ag\u00fcero","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40035-021-00271-0","article-title":"TLR2 and TLR4 in Parkinson\u2019s disease pathogenesis: the environment takes a toll on the gut","volume":"10","author":"Gorecki","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106000","article-title":"Update: Descriptive epidemiology of Parkinson disease","volume":"120","author":"Grotewold","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0180","unstructured":"The Gut-Brain Connection: Why Diet Can Help Parkinson\u2019s Symptoms & Brain Health | Parkinson\u2019s Foundation n.d. https:\/\/www.parkinson.org\/blog\/awareness\/gut-brain-connection (accessed November 30, 2024)."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0185","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.98.18_supplement.946","article-title":"Proof of Concept Study of Prebiotics to Modulate Gut Microbiome in Parkinson\u2019s Disease (P13-11.002)","volume":"98","author":"Hall","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.26865","article-title":"Oxidative stress and neuroinflammation in the story of Parkinson\u2019s disease: could targeting these pathways write a good ending?","volume":"234","author":"Hassanzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0200","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2014.01.052","article-title":"Compositional and functional features of the gastrointestinal microbiome and their effects on human health","volume":"146","author":"Hollister","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0205","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.18632\/aging.204266","article-title":"Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials","volume":"14","author":"Hong","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.copbio.2015.09.001","article-title":"Prebiotics: why definitions matter","volume":"37","author":"Hutkins","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0225","unstructured":"Dietary Interventions to Slow and Improve Parkinson\u2019s Symptoms by Restructuring the Gut Microbiome and Decreasing Inflammation | Parkinson\u2019s Disease n.d. https:\/\/www.michaeljfox.org\/grant\/dietary-interventions-slow-and-improve-parkinsons-symptoms-restructuring-gut-microbiome-and (accessed November 30, 2024)."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0230","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0235","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of Microbiota transfer Therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00392","article-title":"Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders","volume":"9","author":"Kelly","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0245","first-page":"569","article-title":"The role of the gastrointestinal system and gut microbiota in Parkinson\u2019s disease. Genetics, Neurology, Behavior, and Diet in Parkinson\u2019s Disease","author":"Kenna","year":"2020","journal-title":"Elsevier"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0250","doi-asserted-by":"crossref","unstructured":"Keshavarzian, A., Engen, P., Bonvegna, S., Cilia, R., 2020. The gut microbiome in Parkinson\u2019s disease: A culprit or a bystander?, p. 357\u2013450. DOI: 10.1016\/bs.pbr.2020.01.004.","DOI":"10.1016\/bs.pbr.2020.01.004"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s41983-021-00407-z","article-title":"Gut microbiota in Parkinson\u2019s disease patients: hospital-based study","volume":"57","author":"Khedr","year":"2021","journal-title":"Egypt. J. Neurol. Psychiatr. Neurosurg."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","article-title":"Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and \u03b1-synucleinopathies","volume":"81","author":"Kouli","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113159","article-title":"Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson\u2019s disease","volume":"325","author":"Koutzoumis","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson\u2019s disease","volume":"10","author":"Kwon","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0275","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","article-title":"Dopamine in Parkinson\u2019s disease","volume":"522","author":"Latif","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0280","doi-asserted-by":"crossref","first-page":"15062","DOI":"10.1038\/ncomms15062","article-title":"Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior","volume":"8","author":"Leclercq","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0285","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cns.13990","article-title":"Gut bacterial profiles in Parkinson\u2019s disease: a systematic review","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0290","first-page":"1","article-title":"Protection of fecal microbiota transplantation in a mouse model of multiple sclerosis","volume":"2020","author":"Li","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/efd2.156","article-title":"Exploring the therapeutic potential of Bifidobacterium longum subsp. longum CCFM1029 in Parkinson\u2019s disease: Insights from behavioral, neurophysiological, gut microbiota, and microbial metabolites analysis","volume":"5","author":"Li","year":"2024","journal-title":"eFood"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.111067","article-title":"Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson\u2019s disease","volume":"155","author":"Liu","year":"2022","journal-title":"Food Res. Int."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: a double-edged sword for health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0310","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","article-title":"Parkinson\u2019s disease and the gastrointestinal microbiome","volume":"267","author":"Lubomski","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0315","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12035-013-8425-7","article-title":"Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway","volume":"48","author":"Lucas","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0320","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","article-title":"The brain-gut-microbiome axis","volume":"6","author":"Martin","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-021-00273-9","article-title":"Lewy body disease or diseases with Lewy bodies?","volume":"8","author":"Men\u0161\u00edkov\u00e1","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0335","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.27924","article-title":"Antibiotic exposure and risk of parkinson\u2019s disease in finland: a nationwide case\u2010control study","volume":"35","author":"Mertsalmi","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0340","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1038\/srep30028","article-title":"Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease","volume":"6","author":"Minter","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0345","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s10571-021-01128-w","article-title":"Probiotics and the treatment of Parkinson\u2019s disease: an update","volume":"42","author":"Mirzaei","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jare.2022.12.001","article-title":"Brain modulation by the gut microbiota: from disease to therapy","volume":"53","author":"Mitra","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0355","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: a unified framework","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0360","doi-asserted-by":"crossref","first-page":"423.e27","DOI":"10.1016\/j.neurobiolaging.2010.09.025","article-title":"The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons","volume":"33","author":"Mouton","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0365","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3988\/jcn.2017.13.2.181","article-title":"Association of Helicobacter pylori with Parkinson\u2019s Disease","volume":"13","author":"Mridula","year":"2017","journal-title":"Journal of Clinical Neurology"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.652617","article-title":"Desulfovibrio bacteria are associated with Parkinson\u2019s Disease","volume":"11","author":"Murros","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0375","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1017\/S0022029917000620","article-title":"Lactobacilli-fermented cow\u2019s milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment in vitro and in vivo","volume":"84","author":"Musa","year":"2017","journal-title":"J. Dairy Res."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41522-022-00367-z","article-title":"Inflammatory microbes and genes as potential biomarkers of Parkinson\u2019s disease","volume":"8","author":"Nie","year":"2022","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0385","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00797-20","article-title":"Short-chain fatty acid-producing gut microbiota is decreased in Parkinson\u2019s disease but not in rapid-eye-movement sleep behavior disorder","volume":"5","author":"Nishiwaki","year":"2020","journal-title":"Msystems"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0390","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1053\/j.gastro.2016.07.044","article-title":"The effect of microbiota and the immune system on the development and organization of the enteric nervous system","volume":"151","author":"Obata","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107081","article-title":"Effects of antimicrobial exposure on the risk of Parkinson\u2019s disease","volume":"127","author":"Pal","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","article-title":"Gut microbiota: implications in Parkinson\u2019s disease","volume":"38","author":"Parashar","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0410","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/jcm8081191","article-title":"Patients with inflammatory bowel disease are at an increased risk of Parkinson\u2019s disease: a South Korean nationwide population-based study","volume":"8","author":"Park","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0415","unstructured":"Parkinson disease A public health approach. n.d."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0420","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12223-022-00977-2","article-title":"Exploring the multifactorial aspects of Gut Microbiome in Parkinson\u2019s Disease","volume":"67","author":"Pavan","year":"2022","journal-title":"Folia Microbiol. (Praha)"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0425","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0430","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115001","article-title":"Lactiplantibacillus plantarum SG5 inhibits neuroinflammation in MPTP-induced PD mice through GLP-1\/PGC-1\u03b1 pathway","volume":"383","author":"Qi","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0440","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","article-title":"Alteration of the fecal microbiota in chinese patients with Parkinson\u2019s disease","volume":"70","author":"Qian","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0445","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","article-title":"Microbiota-brain-gut axis and neurodegenerative diseases","volume":"17","author":"Quigley","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0450","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0455","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? a changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0465","doi-asserted-by":"crossref","DOI":"10.4314\/njm.v19i2.56496","article-title":"Non-motor symptoms of parkinson\u2019s disease: diagnosis and management","volume":"19","author":"Salawu","year":"2010","journal-title":"Niger. J. Med."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0470","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53111","article-title":"A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice","volume":"9","author":"Sampson","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0475","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0480","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways","volume":"29","author":"Santa-Cec\u00edlia","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0485","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s42269-023-01047-4","article-title":"A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson\u2019s disease with insights into screening models","volume":"47","author":"Sayyaed","year":"2023","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0490","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal microbiota transplantation for treatment of Parkinson disease","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0495","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal microbiota transplantation for treatment of Parkinson Disease","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0500","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal microbiota transplantation for treatment of parkinson disease","author":"Scheperjans","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.831090","article-title":"Gut-derived sterile inflammation and Parkinson\u2019s disease","volume":"13","author":"Shannon","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1122712","article-title":"Effects of levodopa on gut bacterial antibiotic resistance in Parkinson\u2019s disease rat","volume":"15","author":"Sheng","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0515","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0520","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0525","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0530","unstructured":"UCSF Parkinson\u2019s Disease Trial \u2192 Microbiota Intervention to Change the Response of Parkinson\u2019s Disease n.d. https:\/\/clinicaltrials.ucsf.edu\/trial\/NCT03575195 (accessed November 30, 2024)."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1225875","article-title":"The gut microbiota\u2013brain axis in neurological disorder","volume":"17","author":"Ullah","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0540","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0545","doi-asserted-by":"crossref","unstructured":"Valdes, A.M., Walter, J., Segal, E., Spector, T.D., 2018. Role of the gut microbiota in nutrition and health. BMJ k2179. DOI: 10.1136\/bmj.k2179.","DOI":"10.1136\/bmj.k2179"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0550","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.3390\/ijms232012289","article-title":"The interplay between gut microbiota and Parkinson\u2019s disease: implications on diagnosis and treatment","volume":"23","author":"Varesi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0555","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal microbiota transplantation in neurological disorders","volume":"10","author":"Vendrik","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0560","doi-asserted-by":"crossref","DOI":"10.3390\/cells13090770","article-title":"From the gut to the brain: is microbiota a new paradigm in parkinson\u2019s disease treatment?","volume":"13","author":"Vilela","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0565","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/cells13090770","article-title":"From the gut to the brain: is microbiota a new paradigm in Parkinson\u2019s disease treatment?","volume":"13","author":"Vilela","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0570","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/applmicrobiol3030067","article-title":"The potential role of fecal microbiota transplantation in Parkinson\u2019s Disease: a systematic literature review","volume":"3","author":"Vongsavath","year":"2023","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0575","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","article-title":"Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms","volume":"13","author":"Wallen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0580","article-title":"Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0585","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options","volume":"144","author":"Wang","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0590","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1073858421991066","article-title":"Neuroinflammation in Parkinson\u2019s disease: triggers, mechanisms, and immunotherapies","volume":"28","author":"Wang","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0595","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","article-title":"Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson\u2019s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder","volume":"70","author":"Wang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0600","first-page":"3225","article-title":"The microbiota-gut-brain axis as a key regulator of neural function and the stress response: Implications for human and animal health1,2","volume":"95","author":"Wiley","year":"2017","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.730036","article-title":"Efficacy and Safety of probiotics for the treatment of alzheimer\u2019s disease, mild cognitive impairment, and parkinson\u2019s disease: a systematic review and meta-analysis","volume":"14","author":"Xiang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0610","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/2589977513666210315095133","article-title":"Potential of antibiotics for the treatment and management of Parkinson\u2019s disease: an overview","volume":"13","author":"Yadav","year":"2021","journal-title":"Curr. Drug Res. Rev."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0615","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/mds.29063","article-title":"Parkinson\u2019s disease is associated with impaired gut\u2013blood barrier for short\u2010chain fatty acids","volume":"37","author":"Yang","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0620","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01155","article-title":"The role of the gut microbiota in the pathogenesis of Parkinson\u2019s disease","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0625","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1418857","article-title":"Gut microbiota from patients with Parkinson\u2019s disease causes motor deficits in honeybees","volume":"15","author":"Zeng","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0630","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","article-title":"Microbiota transplantation: concept, methodology and strategy for its modernization","volume":"9","author":"Zhang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0635","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0640","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41531-024-00802-2","article-title":"Microbial biomarker discovery in Parkinson\u2019s disease through a network-based approach","volume":"10","author":"Zhao","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0645","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-023-02846-2","article-title":"Lipopolysaccharide-binding protein and future Parkinson\u2019s disease risk: a European prospective cohort","volume":"20","author":"Zhao","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2025.07.003_b0650","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s12264-021-00730-8","article-title":"The relationship between the gut microbiome and neurodegenerative diseases","volume":"37","author":"Zhu","year":"2021","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0655","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/1673-5374.317981","article-title":"Association between inflammatory bowel diseases and Parkinson\u2019s disease: systematic review and meta-analysis","volume":"17","author":"Zhu","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuroscience.2025.07.003_b0660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2015.03.016","article-title":"Food for the brain","volume":"161","author":"Zuker","year":"2015","journal-title":"Cell"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225007651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225007651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T12:08:34Z","timestamp":1753790914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225007651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":132,"alternative-id":["S0306452225007651"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.07.003","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson\u2019s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}